{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:47:32Z","timestamp":1788983252475,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA074397"],"award-info":[{"award-number":["R01 CA074397"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RC2 CA148298"],"award-info":[{"award-number":["RC2 CA148298"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA014089"],"award-info":[{"award-number":["P30 CA014089"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"L.K. Whittier Foundation"},{"DOI":"10.13039\/100009410","name":"SC-CTSI","doi-asserted-by":"crossref","award":["TL1TR000132"],"award-info":[{"award-number":["TL1TR000132"]}],"id":[{"id":"10.13039\/100009410","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.clim.2015.09.003","type":"journal-article","created":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T10:37:14Z","timestamp":1441708634000},"page":"197-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C"],"prefix":"10.1016","volume":"161","author":[{"given":"Diane M.","family":"Da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Woodham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph G.","family":"Skeate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie K.","family":"Rijkee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia R.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike E.","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila I.","family":"Muderspach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda D.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie A.","family":"Yessaian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huyen Q.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne G.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg M.","family":"McKee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres M.","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Martin","family":"Kast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2015.09.003_bb0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.clim.2015.09.003_bb0010","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1086\/341782","article-title":"Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study","volume":"186","author":"Giuliano","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2015.09.003_bb0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections","volume":"100","author":"Rodriguez","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.clim.2015.09.003_bb0020","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ajog.2006.02.047","article-title":"Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS)","volume":"195","author":"Walker","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.clim.2015.09.003_bb0025","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/AOG.0b013e3182883a34","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"121","author":"Massad","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.clim.2015.09.003_bb0030","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.4049\/jimmunol.169.6.3242","article-title":"Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomaviruses","volume":"169","author":"Fausch","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.09.003_bb0035","doi-asserted-by":"crossref","first-page":"7172","DOI":"10.4049\/jimmunol.174.11.7172","article-title":"Human papillomavirus can escape immune recognition through Langerhans cell phosphoinositide 3-kinase activation","volume":"174","author":"Fausch","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.09.003_bb0040","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.virol.2014.01.031","article-title":"Suppression of Langerhans cell activation is conserved amongst human papillomavirus alpha and beta genotypes, but not a mu genotype","volume":"452\u2013453","author":"Da Silva","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.clim.2015.09.003_bb0045","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20131675","article-title":"Modular expression analysis reveals functional conservation between human Langerhans cells and mouse cross-priming dendritic cells","author":"Artyomov","year":"2015","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.clim.2015.09.003_bb0050","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1182\/blood-2011-08-371245","article-title":"The differential production of cytokines by human Langerhans cells and dermal CD14(+) DCs controls CTL priming","volume":"119","author":"Banchereau","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clim.2015.09.003_bb0055","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.immuni.2008.07.013","article-title":"Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells","volume":"29","author":"Klechevsky","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2015.09.003_bb0060","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.4049\/jimmunol.173.4.2780","volume":"173","author":"Ratzinger","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.09.003_bb0065","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/jid.2012.26","article-title":"CD70\u2013CD27 interaction augments CD8+ T-cell activation by human epidermal Langerhans cells","volume":"132","author":"Polak","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.clim.2015.09.003_bb0070","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.it.2010.08.006","article-title":"In vivo function of Langerhans cells and dermal dendritic cells","volume":"31","author":"Kaplan","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.clim.2015.09.003_bb0075","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.coi.2010.08.005","article-title":"Induction of T cell anergy: integration of environmental cues and infectious tolerance","volume":"22","author":"Chappert","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2015.09.003_bb0080","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.clim.2015.09.003_bb0085","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.immunol.26.021607.090254","article-title":"Migration of dendritic cell subsets and their precursors","volume":"26","author":"Randolph","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2015.09.003_bb0090","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nri3683","article-title":"The origins and functions of dendritic cells and macrophages in the skin","volume":"14","author":"Malissen","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2015.09.003_bb0095","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.4049\/jimmunol.0803645","article-title":"Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16","volume":"182","author":"Fahey","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.09.003_bb0100","unstructured":"D.M. Da Silva, A.W. Woodham, L.K. Rijkee, J.G. Skeate, J.R. Taylor, M.E. Koopman, H.E. Brand, M.K. Wong, G.M. McKee, A.M. Salazar, W.M. Kast, Human papillomavirus-exposed Langerhans cells are activated by stabilized Poly-I:C, Papillomavirus Research, (2015) Epub ahead of print. doi:10.1016\/j.pvr.2015.1005.1001."},{"key":"10.1016\/j.clim.2015.09.003_bb0105","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.4161\/cbt.10.12.13450","article-title":"Anticancer function of polyinosinic\u2013polycytidylic acid","volume":"10","author":"Cheng","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.clim.2015.09.003_bb0110","doi-asserted-by":"crossref","first-page":"7959","DOI":"10.4049\/jimmunol.177.11.7959","article-title":"Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria","volume":"177","author":"Flacher","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.09.003_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1443.020","article-title":"Toll-like receptor and RIG-I-like receptor signaling","volume":"1143","author":"Kawai","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.clim.2015.09.003_bb0120","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.addr.2007.11.005","article-title":"TLR3: interferon induction by double-stranded RNA including poly(I:C)","volume":"60","author":"Matsumoto","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.clim.2015.09.003_bb0125","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1038\/jid.2009.21","article-title":"Poly(I:C)-treated human Langerhans cells promote the differentiation of CD4+ T cells producing IFN-gamma and IL-10","volume":"129","author":"Furio","year":"2009","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.clim.2015.09.003_bb0130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1432-1033.1979.tb12807.x","article-title":"Degradation of poly(inosinic acid)\u2013poly(cytidylic acid) [(I)n\u2013(C)n] by human plasma","volume":"93","author":"de Clercq","year":"1979","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.clim.2015.09.003_bb0135","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/infdis\/132.4.434","article-title":"A modified polyriboinosinic\u2013polyribocytidylic acid complex that induces interferon in primates","volume":"132","author":"Levy","year":"1975","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2015.09.003_bb0140","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1073\/pnas.95.4.1800","article-title":"Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model","volume":"95","author":"Greenstone","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2015.09.003_bb0145","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-4939-2013-6_10","article-title":"Molecular analysis of human papillomavirus virus-like particle activated Langerhans cells in vitro","volume":"1249","author":"Woodham","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.clim.2015.09.003_bb0150","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-1-4939-2013-6_25","article-title":"Functional analysis of HPV-like particle-activated Langerhans cells in vitro","volume":"1249","author":"Yan","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.clim.2015.09.003_bb0155","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.clim.2015.09.003_bb0160","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/1471-2164-9-328","article-title":"Cross-platform comparison of SYBR Green real-time PCR with TaqMan PCR, microarrays and other gene expression measurement technologies evaluated in the MicroArray Quality Control (MAQC) study","volume":"9","author":"Arikawa","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1016\/j.clim.2015.09.003_bb0165","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.4049\/jimmunol.152.8.3904","article-title":"Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins","volume":"152","author":"Kast","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.09.003_bb0170","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/CEJ.0b013e3282f75ea1","article-title":"HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy","volume":"17","author":"De Vuyst","year":"2008","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.clim.2015.09.003_bb0175","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.clim.2015.09.003_bb0180","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1073\/pnas.95.4.1800","article-title":"Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model","volume":"95","author":"Greenstone","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2015.09.003_bb0185","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1158\/2326-6066.CIR-14-0024","article-title":"Therapeutic in situ autovaccination against solid cancers with intratumoral poly-ICLC: case report, hypothesis, and clinical trial","volume":"2","author":"Salazar","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.clim.2015.09.003_bb0190","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1200\/JCO.2010.30.7744","volume":"29","author":"Okada","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.clim.2015.09.003_bb0195","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1158\/1078-0432.CCR-10-2563","article-title":"Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy","volume":"17","author":"Prins","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.clim.2015.09.003_bb0200","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1126\/science.1179050","article-title":"Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses","volume":"326","author":"Amit","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.clim.2015.09.003_bb0205","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1084\/jem.20111171","article-title":"Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans","volume":"208","author":"Caskey","year":"2011","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.clim.2015.09.003_bb0210","doi-asserted-by":"crossref","first-page":"156","DOI":"10.12788\/jcso.0039","article-title":"Cobas HPV test for first-line screening for cervical cancer","volume":"12","author":"Abraham","year":"2014","journal-title":"J Community Support Oncol"},{"key":"10.1016\/j.clim.2015.09.003_bb0215","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.clim.2015.09.003_bb0220","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.clim.2015.09.003_bb0225","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1309\/AJCPZ5JY6FCVNMOT","article-title":"High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study","volume":"135","author":"Stoler","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.clim.2015.09.003_bb0230","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/CMR.05028-11","article-title":"Epithelial cell responses to infection with human papillomavirus","volume":"25","author":"Stanley","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.clim.2015.09.003_bb0235","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/ijc.10084","article-title":"Influence of the mucosal epithelium microenvironment on Langerhans cells: implications for the development of squamous intraepithelial lesions of the cervix","volume":"97","author":"Giannini","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.clim.2015.09.003_bb0240","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2249.1999.00826.x","article-title":"The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium","volume":"116","author":"Mota","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2015.09.003_bb0245","doi-asserted-by":"crossref","DOI":"10.1111\/imm.12487","article-title":"Local immunosuppression induced by high viral load of human papillomavirus: characterization of cellular phenotypes producing interleukin-10 in cervical neoplastic lesions","author":"Prata","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2015.09.003_bb0250","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.4049\/jimmunol.166.9.5346","article-title":"Papillomavirus-like particles induce acute activation of dendritic cells","volume":"166","author":"Lenz","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.09.003_bb0255","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/eji.200425547","article-title":"Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells","volume":"35","author":"Lenz","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2015.09.003_bb0260","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1521-6616(02)00039-6","article-title":"Interaction of papillomavirus virus-like particles with human myeloid antigen-presenting cells","volume":"106","author":"Lenz","year":"2003","journal-title":"Clin. Immunol"},{"key":"10.1016\/j.clim.2015.09.003_bb0265","doi-asserted-by":"crossref","first-page":"5917","DOI":"10.4049\/jimmunol.166.10.5917","article-title":"Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro","volume":"166","author":"Rudolf","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.09.003_bb0270","doi-asserted-by":"crossref","first-page":"7587","DOI":"10.4049\/jimmunol.178.12.7587","article-title":"Uptake of human papillomavirus virus-like particles by dendritic cells is mediated by Fc{gamma} receptors and contributes to acquisition of T cell immunity","volume":"178","author":"Da Silva","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.09.003_bb0275","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.4049\/jimmunol.0902145","article-title":"A major role for the minor capsid protein of human papillomavirus type 16 in immune escape","volume":"183","author":"Fahey","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.09.003_bb0280","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.4049\/jimmunol.1303190","article-title":"Inhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppression","volume":"192","author":"Woodham","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.09.003_bb0285","first-page":"1907","article-title":"Phase I-II trials of poly IC stabilized with poly-l-lysine","volume":"62","author":"Levine","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.clim.2015.09.003_bb0290","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.virol.2010.07.044","article-title":"HPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8 T cells","volume":"407","author":"Campo","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.clim.2015.09.003_bb0295","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/clim.2001.5094","article-title":"Interaction of human papillomavirus type 11 E7 protein with TAP-1 results in the reduction of ATP-dependent peptide transport","volume":"101","author":"Vambutas","year":"2001","journal-title":"Clin. Immunol"},{"key":"10.1016\/j.clim.2015.09.003_bb0300","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.clim.2005.02.001","article-title":"Integration of high-risk human papillomavirus DNA correlates with HLA genotype aberration and reduced HLA class I molecule expression in human cervical carcinoma","volume":"115","author":"Sheu","year":"2005","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2015.09.003_bb0305","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clim.2004.11.005","article-title":"Preservation and redirection of HPV16E7-specific T cell receptors for immunotherapy of cervical cancer","volume":"114","author":"Scholten","year":"2005","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2015.09.003_bb0310","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1479-5876-9-147","article-title":"Generating HPV specific T helper cells for the treatment of HPV induced malignancies using TCR gene transfer","volume":"9","author":"Scholten","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.clim.2015.09.003_bb0315","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1086\/315706","article-title":"Persistence of human papillomavirus type 16 infection is associated with lack of cytotoxic T lymphocyte response to the E6 antigens","volume":"182","author":"Nakagawa","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2015.09.003_bb0320","first-page":"582","article-title":"Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A *0201-restricted E7-encoded epitope","volume":"56","author":"Ressing","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.clim.2015.09.003_bb0325","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/IGC.0b013e3181a388c4","article-title":"Cell-mediated immune responses to human papillomavirus 16 E6 and E7 antigens as measured by interferon gamma enzyme-linked immunospot in women with cleared or persistent human papillomavirus infection","volume":"19","author":"Farhat","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.clim.2015.09.003_bb0330","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4049\/jimmunol.177.1.298","article-title":"TLR activation of Langerhans cell-like dendritic cells triggers an antiviral immune response","volume":"177","author":"Renn","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.09.003_bb0335","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1095\/biolreprod.105.048629","article-title":"Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens","volume":"74","author":"Andersen","year":"2006","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.clim.2015.09.003_bb0340","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1034\/j.1600-0463.2003.11107805.x","article-title":"Langerhans cells\u2014dendritic cells of the epidermis","volume":"111","author":"Romani","year":"2003","journal-title":"APMIS"},{"key":"10.1016\/j.clim.2015.09.003_bb0345","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2567.2005.02282.x","article-title":"High-risk human papilloma virus infection decreases the frequency of dendritic Langerhans' cells in the human female genital tract","volume":"117","author":"Jimenez-Flores","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2015.09.003_bb0350","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1365-2133.2010.09968.x","article-title":"Deregulation of E-cadherin by human papillomavirus is not confined to high-risk, cancer-causing types","volume":"163","author":"Leong","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2015.09.003_bb0355","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/jid.2009.266","article-title":"Loss of epidermal Langerhans cells occurs in human papillomavirus alpha, gamma, and mu but not beta genus infections","volume":"130","author":"Leong","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.clim.2015.09.003_bb0360","doi-asserted-by":"crossref","first-page":"785825","DOI":"10.1155\/2012\/785825","article-title":"Toll-like receptor transcriptome in the HPV-positive cervical cancer microenvironment","volume":"2012","author":"DeCarlo","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.clim.2015.09.003_bb0365","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/ijc.29283","article-title":"Expression of nucleic acid-sensing Toll-like receptors predicts HPV16 clearance associated with an E6-directed cell-mediated response","volume":"136","author":"Scott","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.clim.2015.09.003_bb0370","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/ijc.25400","article-title":"Moscicki, association between toll-like receptor expression and human papillomavirus type 16 persistence","volume":"128","author":"Daud","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.clim.2015.09.003_bb0375","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/MPH.0000000000000047","article-title":"Pediatric phase II trials of poly-ICLC in the management of newly diagnosed and recurrent brain tumors","volume":"36","author":"Hartman","year":"2014","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.clim.2015.09.003_bb0380","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/neuonc\/noq071","article-title":"A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma","volume":"12","author":"Rosenfeld","year":"2010","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.clim.2015.09.003_bb0385","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1227\/00006123-199606000-00006","article-title":"Long-term treatment of malignant gliomas with intramuscularly administered polyinosinic\u2013polycytidylic acid stabilized with polylysine and carboxymethylcellulose: an open pilot study","volume":"38","author":"Salazar","year":"1996","journal-title":"Neurosurgery"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661615300371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661615300371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T21:34:18Z","timestamp":1691962458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661615300371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1521661615300371"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2015.09.003","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2015.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}